Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies

被引：0
|
作者：
Schreiber, S. [1 ]
Loftus, E. V., Jr. [2 ]
Maaser, C. [3 ]
Danese, S. [4 ,5 ]
Rudolph, C. [6 ]
Jongen, R. [6 ]
De Haas, A. [6 ]
Oortwijn, A. [6 ]
Vermeire, S. [7 ]
机构：
[1] Univ Kiel, Med 1, Kiel, Germany
[2] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN USA
[3] Hosp Luneburg, Outpatients Dept Gastroenterol, Luneburg, Germany
[4] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[5] San Raffaele Univ, Vita Salute, Milan, Italy
[6] Galapagos Nv, Leiden, Netherlands
[7] Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP37
引用
收藏
页码：I085 / I087
页数：3
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY AGE: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION AND SELECTIONLTE STUDIES
    Schreiber, Stefan
    Loftus, Edward V.
    Maaser, Christian
    Danese, Silvio
    Rudolph, Christine
    Jongen, Rob
    de Haas, Angela
    Oortwijn, Alessandra
    Vermeire, Severine
    GASTROENTEROLOGY, 2022, 162 (07) : S633 - S634
  • [2] Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies
    Vermeire, Severine
    Feagan, Brian G.
    Peyrin-Biroulet, Laurent
    Oortwijn, Alessandra
    Faes, Margaux
    de Haas, Angela
    Rogler, Gerhard
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 54 - 64
  • [3] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study
    Watanabe, Kenji
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Fujitani, Yasushi
    Faes, Margaux
    Oortwijn, Alessandra
    Lindsay, James O.
    Rogler, Gerhard
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
  • [4] Predicting late responders to filgotinib in patients with ulcerative colitis: a post hoc analysis of SELECTION and SELECTIONLTE
    Beales, Ian
    Matsuoka, Katsuyoshi
    Lowenberg, Mark
    Fumery, Mathurin
    Takatori, Yoshie
    Fujitani, Yasushi
    Oortwijn, Alessandra
    Faes, Margaux
    Jamoul, Corinne
    Hibi, Toshifumi
    GUT, 2023, 72 (SUPPL_2) : A76 - A76
  • [5] Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
    Schreiber, S. W.
    Watanabe, M.
    Yun, C.
    Zhou, Y.
    Zhao, S.
    Hsieh, J.
    Moerch, U.
    Rogler, G.
    Loftus, E. V., Jr.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S004 - S005
  • [6] SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTIONLTE LONG-TERM EXTENSION STUDY
    Schreiber, Stefan
    Loftus, Edward V.
    Rogler, Gerhard
    Yun, Chohee
    Zhou, Yan
    Zhao, Sally
    Hsieh, Jeremy
    Moerch, Ulrik
    Watanabe, Mamoru
    GASTROENTEROLOGY, 2021, 160 (06) : S37 - S38
  • [7] Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial
    Peyrin-Biroulet, L.
    Dotan, I.
    Hibi, T.
    Thliadouros, V.
    Oortwijn, A.
    Zhao, S.
    Zhang, J.
    Hsieh, J.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S024 - S025
  • [8] Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial
    Dotan, Iris
    Feagan, Brian G.
    Taliadouros, Virginia
    Oortwijn, Alessandra
    Rudolph, Christine
    de Haas, Angela
    Santermans, Eva
    Hsieh, Jeremy
    Peyrin-Biroulet, Laurent
    Hibi, Toshifumi
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1207 - 1216
  • [9] FILGOTINIB EFFICACY IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY: PHASE 2B/3 SELECTION RESULTS
    Morison, Ben
    Peyrin-Biroulet, Lauren
    Dotan, Iris
    Hibi, Toshifumi
    Taliadouros, Virginia
    Oortwijn, Alessandra
    Zhao, Sally
    Zhang, Jie
    Hsieh, Jeremy
    Feagan, Brian
    GUT, 2021, 70 : A5 - A6
  • [10] Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
    Hibi, Toshifumi
    Motoya, Satoshi
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Watanabe, Kenji
    Matsuoka, Katsuyoshi
    Saruta, Masayuki
    Kobayashi, Taku
    Feagan, Brian G.
    Tasset, Chantal
    Besuyen, Robin
    Yun, Chohee
    Crans, Gerald
    Zhang, Jie
    Kondo, Akira
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2022, : 110 - 125
12345